HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 280, Issue 4, 2569-2578, January 28, 2005

This Article Full Text Full Text (PDF) All Versions of this Article: 280/4/2569    most recent M410179200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Harris, C. L. Articles by Lea, S. M. Search for Related Content PubMed PubMed Citation Articles by Harris, C. L. Articles by Lea, S. M. Social Bookmarking                      What's this?

Molecular Dissection of Interactions between Components of the Alternative Pathway of Complement and Decay Accelerating Factor (CD55)^*

Claire L. Harris, Rachel J. M. Abbott¶||, Richard A. Smith**, B. Paul Morgan, and Susan M. Lea¶

From the Complement Biology Group, Department of Medical Biochemistry and Immunology, School of Medicine, Cardiff University, Heath Park, Cardiff, CF14 4XN, ^¶Department of Biochemistry, Laboratory of Molecular Biophysics, Oxford University, South Parks Road, Oxford OX1 3QU, and ^**Adprotech Ltd., Chesterford Research Park, Little Chesterford, Essex, CB10 1XL, United Kingdom

The complement regulatory protein decay accelerating factor (DAF; CD55), inhibits the alternative complement pathway by accelerating decay of the convertase enzymes formed by C3b and factor B. We show, using surface plasmon resonance, that in the absence of Mg²⁺, DAF binds C3b, factor B, and the Bb subunit with low affinity (K_D, 14 ± 0.1, 44 ± 10, and 20 ± 7 µM, respectively). In the presence of Mg²⁺, DAF bound Bb or the von Willebrand factor type A subunit of Bb with higher affinities (K_D, 1.3 ± 0.5 and 2.2 ± 0.1 µM, respectively). Interaction with the proenzyme C3bB was investigated by flowing factor B across a C3b-coated surface in the absence of factor D. The dissociation rate was dependent on the time of incubation, suggesting that a time-dependent conformational transition stabilized the C3b-factor B interaction. Activation by factor D (forming C3bBb) increased the complex half-life; however, the enzyme became susceptible to rapid decay by DAF, unlike the proenzyme, which was unaffected. A convertase assembled with cobra venom factor and Bb was decayed by DAF, albeit far less efficiently than C3bBb. DAF did not bind cobra venom factor, implying that Bb decay is accelerated, at least in part, through DAF binding of this subunit. It is likely that DAF binds the complex with higher affinity/avidity, promoting a conformational change in either or both subunits accelerating decay. Such analysis of component and regulator interactions will inform our understanding of inhibitory mechanisms and the ways in which regulatory proteins cooperate to control the complement cascade.

Received for publication, September 3, 2004 , and in revised form, November 5, 2004.

^* This work was supported by the Wellcome Trust (Grant 068823/Z). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

^|| Supported by a Medical Research Council studentship.

To whom correspondence should be addressed: Henry Wellcome Building, Heath Park, Cardiff, CF14 4XN, UK. Tel.: 44-29-20745254; Fax: 44-29-20744001; E-mail: harriscl{at}cardiff.ac.uk.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. Caprioli and G. Remuzzi Complement hyperactivation may cause atypical haemolytic uraemic syndrome gain-of-function mutations in factor B Nephrol. Dial. Transplant., September 1, 2007; 22(9): 2452 - 2454. [Full Text] [PDF]

				E. G. de Jorge, C. L. Harris, J. Esparza-Gordillo, L. Carreras, E. A. Arranz, C. A. Garrido, M. Lopez-Trascasa, P. Sanchez-Corral, B. P. Morgan, and S. R. de Cordoba Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome PNAS, January 2, 2007; 104(1): 240 - 245. [Abstract] [Full Text] [PDF]

				C. L. Harris, D. M. Pettigrew, S. M. Lea, and B. P. Morgan Decay-Accelerating Factor Must Bind Both Components of the Complement Alternative Pathway C3 Convertase to Mediate Efficient Decay J. Immunol., January 1, 2007; 178(1): 352 - 359. [Abstract] [Full Text] [PDF]

				A. K. Singh, J. Mullick, J. Bernet, and A. Sahu Functional Characterization of the Complement Control Protein Homolog of Herpesvirus Saimiri: ARG-118 IS CRITICAL FOR FACTOR I COFACTOR ACTIVITIES J. Biol. Chem., August 11, 2006; 281(32): 23119 - 23128. [Abstract] [Full Text] [PDF]

				M. K. Liszewski, M. K. Leung, R. Hauhart, R. M. L. Buller, P. Bertram, X. Wang, A. M. Rosengard, G. J. Kotwal, and J. P. Atkinson Structure and Regulatory Profile of the Monkeypox Inhibitor of Complement: Comparison to Homologs in Vaccinia and Variola and Evidence for Dimer Formation J. Immunol., March 15, 2006; 176(6): 3725 - 3734. [Abstract] [Full Text] [PDF]

				D. E. Hourcade The Role of Properdin in the Assembly of the Alternative Pathway C3 Convertases of Complement J. Biol. Chem., January 27, 2006; 281(4): 2128 - 2132. [Abstract] [Full Text] [PDF]